Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqac138 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Mercedes A de la Cruz Jasso und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pathology and Anatomic Pathology. Hauptthemen laut MEDLINE: Kidney, Amyloid Neuropathies, Familial. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Objectives
To assess the prevalence of leukocyte cell-derived chemotactic 2 (LECT2), its organ involvement, and its clinical association in autopsies from an ethnically biased population.
Methods
The tissues from all autopsies of individuals diagnosed with amyloidosis were reassessed and typed for amyloid light chain (AL) amyloidosis, amyloid A (AA) amyloidosis, transthyretin amyloidosis (ATTR), and leukocyte chemotactic factor 2 amyloidosis (ALECT2) by immunohistochemistry. Organ involvement was described and correlated with its clinical associations.
Results
Of 782 autopsies, 27 (3.5%) had a confirmed diagnosis of amyloidosis. Of these, 14 (52%) corresponded to ALECT2, 5 (19%) to AL amyloidosis, 2 (7%) to ATTR amyloidosis, 1 (4%) to AA amyloidosis, and 5 (21%) as undetermined-type amyloidosis. The LECT2 amyloid deposits were found in the kidneys, liver, spleen, and adrenal glands in most individuals. Except for the kidneys, there were no clinical signs suggestive of amyloid deposition in most of the affected organs. LECT2 amyloidosis was not associated with the cause of death in any case. No cases had heart or brain involvement. Potential subclinical effects of amyloid deposition in organs such as adrenal glands and spleen require further study.
Conclusions
This autopsy study confirms the high prevalence of LECT2 amyloidosis in the Mexican population, with frequent amyloid deposition in the kidneys, liver, spleen, and adrenal glands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology and Anatomic Pathology.
- Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexicoand.
- Department of Pathology, University of South Alabama, Mobile, AL, USA.
Zitieren
APA
de la Cruz Jasso, M. A., Mejía-Vilet, J. M., Del Toro-Cisneros, N., Aguilar-León, D. E., Morales-Buenrostro, L. E., Herrera, G., & Uribe-Uribe, N. O. (2023). Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac138
Vancouver
de la Cruz Jasso MA, Mejía-Vilet JM, Del Toro-Cisneros N, Aguilar-León DE, Morales-Buenrostro LE, Herrera G, et al. Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac138
BibTeX
@article{delaCruzJasso2023,
author = {de la Cruz Jasso, Mercedes A and Mejía-Vilet, Juan M and Del Toro-Cisneros, Noemí and Aguilar-León, Diana E and Morales-Buenrostro, Luis E and Herrera, Guillermo and Uribe-Uribe, Norma O},
title = {Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqac138}
}
EUVIMED